Evidence map›Paper›PMID 27978939›Full record

ArticleJournal of the International AIDS Society2016

Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings.

Naoko Ishikawa, Shona Dalal, Cheryl Johnson, Daniel R Hogan, Takuro Shimbo, Nathan Shaffer, Razia N Pendse, Ying-Ru Lo, Massimo N Ghidinelli, Rachel Baggaley

Abstract readComparative Study
In one paragraph

Article in Journal of the International AIDS Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Naoko IshikawaDivision of Communicable Diseases, World Health Organization Regional Office for the Western Pacific, Manila, Philippines; ishikawan@who.int.
Shona DalalDepartment of HIV/AIDS, World Health Organization, Geneva, Switzerland.
Cheryl JohnsonDepartment of HIV/AIDS, World Health Organization, Geneva, Switzerland.
Daniel R HoganDepartment of Health Statistics and Information Systems, World Health Organization, Geneva, Switzerland.
Takuro ShimboOta Nishinouchi Hospital, Fukushima, Japan.
Nathan ShafferDepartment of HIV/AIDS, World Health Organization, Geneva, Switzerland.
Razia N PendseCommunicable Diseases Department, World Health Organization Regional Office for the South-East Asia, New Delhi, India.
Ying-Ru LoDivision of Communicable Diseases, World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
Massimo N GhidinelliCommunicable Diseases and Health Analysis, Pan American Health Organization, Washington, DC, USA.
Rachel BaggaleyDepartment of HIV/AIDS, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionHIV testing is the entry point for the elimination of mother-to-child transmission of HIV. Decreasing external funding for the HIV response in some low- and middle-income countries has triggered the question of whether a focused approach to HIV testing targeting pregnant women in high-burden areas should be considered. This study aimed at determining and comparing the cost-effectiveness of universal and focused HIV testing approaches for pregnant women across high to very low HIV prevalence settings.

methodsWe conducted a modelling analysis on health and cost outcomes of HIV testing for pregnant women using four country-based case scenarios (Namibia, Kenya, Haiti and Viet Nam) to illustrate high, intermediate, low and very low HIV prevalence settings. We used subnational prevalence data to divide each country into high-, medium- and low-burden areas, and modelled different antenatal and testing coverage in each.

resultsWhen HIV testing services were only focused in high-burden areas within a country, mother-to-child transmission rates remained high ranging from 18 to 23%, resulting in a 25 to 69% increase in new paediatric HIV infections and increased future treatment costs for children. Universal HIV testing was found to be dominant (i.e. more QALYs gained with less cost) compared to focused approaches in the Namibia, Kenya and Haiti scenarios. The universal approach was also very cost-effective compared to focused approaches, with $ 125 per quality-adjusted life years gained in the Viet Nam-based scenario of very low HIV prevalence. Sensitivity analysis further supported the findings.

conclusionsUniversal approach to antenatal HIV testing achieves the best health outcomes and is cost-saving or cost-effective in the long term across the range of HIV prevalence settings. It is further a prerequisite for quality maternal and child healthcare and for the elimination of mother-to-child transmission of HIV.

Indexed as

AdolescentAdultAIDS SerodiagnosisCost-Benefit AnalysisFemaleHaitiHIV InfectionsHumansInfectious Disease Transmission, VerticalKenyaMass ScreeningMiddle AgedNamibiaPregnancyPregnancy Complications, InfectiousPrenatal Diagnosiscost-effectivenessfocused approachHIVHIV testingmother-to-child transmissionuniversal approach

Identifiers

PMID27978939
PMCPMC5159683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.